» Articles » PMID: 939

Letter: Beta-Blockers and Myasthenia Gravis

Overview
Journal Ann Intern Med
Specialty General Medicine
Date 1975 Dec 1
PMID 939
Citations 9
Authors
Affiliations
Soon will be listed here.
Citing Articles

Comorbidity in myasthenia gravis: multicentric, hospital-based, and controlled study of 178 Italian patients.

Di Stefano V, Iacono S, Militello M, Leone O, Rispoli M, Ferri L Neurol Sci. 2024; 45(7):3481-3494.

PMID: 38383750 PMC: 11176220. DOI: 10.1007/s10072-024-07368-0.


Evaluation of Medication Exposure on Exacerbation of Disease in Patients With Myasthenia Gravis.

Petrucelli N, Barra M, Koehl J Neurohospitalist. 2024; 14(1):52-57.

PMID: 38235027 PMC: 10790617. DOI: 10.1177/19418744231206256.


Antibody Therapies in Autoimmune Neuromuscular Junction Disorders: Approach to Myasthenic Crisis and Chronic Management.

Vanoli F, Mantegazza R Neurotherapeutics. 2022; 19(3):897-910.

PMID: 35165857 PMC: 9294078. DOI: 10.1007/s13311-022-01181-3.


Drugs That Induce or Cause Deterioration of Myasthenia Gravis: An Update.

Sheikh S, Alvi U, Soliven B, Rezania K J Clin Med. 2021; 10(7).

PMID: 33917535 PMC: 8038781. DOI: 10.3390/jcm10071537.


See-Saw Relationship and its Reversal after Immunotherapy in a Case of Graves' Disease with Coexisting Myasthenia Gravis.

Mallikarjuna S, Velayutham S, Sowmini P, Jeyaraj M, Arunan S J Neurosci Rural Pract. 2019; 10(1):136-138.

PMID: 30765989 PMC: 6337967. DOI: 10.4103/jnrp.jnrp_150_18.